BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, November 23, 2024
Home
»
Topics
»
Regulatory
» NMPA
NMPA
RSS
China becomes first country to approve roxadustat
Dec. 18, 2018
No Comments
China SFDA clears phase I trial of A-319 in B-cell malignancies
Nov. 13, 2018
No Comments
Elunate approved in China for colorectal cancer
Sep. 5, 2018
No Comments
CFDA approves INDs for Innovent's IBI-101 and IBI-307
July 27, 2018
No Comments
Luye cleared for phase I trials in China with LY-03012
June 21, 2018
No Comments
CFDA grants priority review to Pharnext's PXT-3003 for CMT1A
June 14, 2018
No Comments
Ganovo approved in China for hepatitis C
June 13, 2018
No Comments
CFDA clears HG-146 to enter clinical trials for multiple myeloma
May 11, 2018
No Comments
CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026
April 16, 2018
No Comments
Chinese authorities approve clinical trials of ZKAB-001
Jan. 30, 2018
No Comments
Previous
1
2
…
36
37
38
39
40
41
42
43
44
45
46
Next
RSS